Micrornas Has-Mir-22-3p and Has-Mir-125b-5p as Diagnostic Biomarkers of Psychotic Disorders

doi 10.36295/asro.2019.22127
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Africa Health Research Organization

Related search

CREB1 Is Affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and Correlates With Adverse Clinicopathological Features in Renal Cell Carcinoma

Scientific Reports
Multidisciplinary
2020English

Evaluation of MicroRNAs miR-196a, miR-30a-5P, and miR-490 as Biomarkers of Disease Activity Among Patients With FSGS

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2014English

Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia

Asian Pacific Journal of Cancer Prevention
2019English

Combined Detection of miR-21-5p, miR-30a-3p, miR-30a-5p, miR-155-5p, miR-216a and miR-217 for Screening of Early Heart Failure Diseases

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2020English

The Clinical Significance of Downregulation of Mir-124-3p, Mir-146a-5p, Mir-155-5p and Mir-335-5p in Gastric Cancer Tumorigenesis

International Journal of Oncology
Cancer ResearchOncology
2014English

Circulating miR-23b-3p, miR-145-5p and miR-200b-3p Are Potential Biomarkers to Monitor Acute Pain Associated With Laminitis in Horses

Animal
Animal ScienceZoology
2017English

MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic Β-Cells

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Plasma miR-324-3p and miR-1285 as Diagnostic and Prognostic Biomarkers for Early Stage Lung Squamous Cell Carcinoma

Oncotarget
Oncology
2016English

Serum miR‑338‑5p Has Potential for Use as a Tumor Marker for Retinoblastoma

Oncology Letters
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy